None listed
Conditions
Interventions
Drug : For the patients of the study group, an commercial anti-adhesive agent GCP500(Mediclo) is applied around the greater auricular nerve after the parotidectomy. For the patients of the control gro
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subject who satisfy all the conditions below 1) Age between 20 and 80 male or female 2) Patients who are planned to undergo parotidectomy 3) Patients who agree to participate in the study spontaneously and receive written consent.
Exclusion criteria
Exclusion criteria: Subject who satisfy at least one condition below 1) Patients who undergo bilateral parotidectomy 2) Patients who are diagnosed as malignant tumor before or after the surgery 3) Patients who have a history of chemotherapy or radiation therapy 4) Patients who have trauma history near the auricle 5) Patients who have central/peripheral nervous disorders or psychiatric diseases 6) Pregnant or lactating women. Patients who are planning to be pregnant during the period of study 7) Patients who have taken other medicines or medical devices by participating another clinical trials 8) Patients who are considered to be improper by the examiner
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensation of periauricular area;questionnaire for quality of life | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative amount of bleeding | — |
Countries
Korea, Republic of
Contacts
Public ContactInn-chul Nam
The Catholic University of Korea, Incheon St. Mary's Hospital
Outcome results
None listed